Since the first connection between Fenton chemistry and biomedicine, numerous studies
have been presented in this field. Comprehensive presentation of the guidance from Fenton …

The blood-brain barrier (BBB) constitutes a microvascular network responsible for excluding
most drugs from the brain. Treatment of brain tumors is limited by the impermeability of the …

Precisely engineered magnetic nanoparticles (MNPs) have been widely explored for
applications including theragnostic platforms, drug delivery systems, biomaterial/device …

The greatest obstacle to using drugs to treat brain tumors is the blood‐brain barrier (BBB),
making it difficult for conventional drug molecules to enter the brain. Therefore, how to safely …

The transition elements (groups IIIB to IIB)-based materials present advantageous
morphological and physicochemical attributes due to the exceptionally variable valence …

Glioma is a common primary brain malignancy with a poor prognosis. Chemotherapy is the
first‐line treatment for brain tumors but low efficiency of drugs in crossing the blood–brain …

The specificity of the tumor microenvironment (TME) severely limits the effectiveness of
tumor treatment. In this study, we prepared a composite nanoparticle of manganese dioxide …

Photodynamic therapy (PDT) as a noninvasive therapy mode has attracted considerable
attention in the field of oncotherapy. However, the PDT efficacy is restricted either by the …

Exosomes are cell-derived vesicles with a lipid bilayer membrane that play important roles
in intercellular communication. They provide an unprecedented opportunity for the …

Hypoxia is a unique characteristic of the solid tumor microenvironment. Hypoxia contributes
to multi-drug resistance, metastasis and cancer relapse through numerous molecular …